{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:48:50Z","timestamp":1782031730471,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100031563","name":"Leeds Hospitals Charity","doi-asserted-by":"publisher","award":["A2002239"],"award-info":[{"award-number":["A2002239"]}],"id":[{"id":"10.13039\/100031563","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijrobp.2025.11.033","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:50:34Z","timestamp":1776347434000},"page":"188-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges and Solutions in Conducting Randomized Controlled Trials Evaluating Prostate SBRT: Lessons Learned From the RO-PIP Trial"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5325-3739","authenticated-orcid":false,"given":"Jim","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finbar","family":"Slevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.11.033_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068580","article-title":"Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)","volume":"12","author":"Zhong","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0002","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bju.13900","article-title":"Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy","volume":"120","author":"Huddart","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0003","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00118-2020","article-title":"SABRTooth: A randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection","volume":"56","author":"Franks","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-6215-15-5","article-title":"Clear obstacles and hidden challenges: Understanding recruiter perspectives in six pragmatic randomised controlled trials","volume":"15","author":"Donovan","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0005","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1054\/bjoc.2000.1142","article-title":"Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy","volume":"82","author":"Jenkins","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3564231","article-title":"Therapeutic misconception in clinical research: Frequency and risk factors","volume":"26","author":"Appelbaum","year":"2004","journal-title":"IRB"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0007","first-page":"202","article-title":"A simple way to make trials more efficient? Patients\u2019 and recruiters\u2019 perspectives on the \u2018timing\u2019 of consent in randomised controlled trials","volume":"12","author":"Paramasivan","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2024.103732","article-title":"Best practice for patient-centred radiotherapy in clinical trials and beyond-A National Multidisciplinary Consensus","volume":"39","author":"Green","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002147","article-title":"Conveying equipoise during recruitment for clinical trials: Qualitative synthesis of recruiters\u2019 practices across six randomised controlled trials","volume":"13","author":"Rooshenas","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13063-016-1391-4","article-title":"Optimising recruitment and informed consent in randomised controlled trials: The development and implementation of the QuinteT Recruitment Intervention (QRI)","volume":"17","author":"Donovan","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0011","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1177\/1049732319828693","article-title":"Intensive triangulation of qualitative research and quantitative data to improve recruitment to randomized trials: The QuinteT approach","volume":"29","author":"Rooshenas","year":"2019","journal-title":"Qual Health Res"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0012","unstructured":"NIHR. Improving Inclusion of Under-Served Groups in Clinical Research: Guidance from the NIHR-INCLUDE Project. NIHR; 2020. Accessed October 26, 2016. www.nihr.ac.uk\/documents\/improving-inclusion-of-under-served-groups-in-clinical-research-guidance-from-include-project\/25435"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0013","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_100040","article-title":"Pragmaticism in cancer clinical trials","volume":"44","author":"Sankar","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108663","article-title":"An introduction to pragmatic trials in lung cancer research: A multi-faceted approach","volume":"206","author":"Bowen Jones","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0015","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S1470-2045(24)00756-3","article-title":"Defining the role of pragmatic clinical trials in cancer clinical research: Outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer","volume":"26","author":"Cardoso Borges","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0016","doi-asserted-by":"crossref","first-page":"c1066","DOI":"10.1136\/bmj.c1066","article-title":"Rethinking pragmatic randomised controlled trials: Introducing the \"cohort multiple randomised controlled trial\" design","volume":"340","author":"Relton","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2025.11.033_bib0017","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/CLEP.S242097","article-title":"Synthetic and external controls in clinical trials - a primer for researchers","volume":"12","author":"Thorlund","year":"2020","journal-title":"Clin Epidemiol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625065009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625065009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:34:07Z","timestamp":1782030847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625065009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0360301625065009"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.11.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and Solutions in Conducting Randomized Controlled Trials Evaluating Prostate SBRT: Lessons Learned From the RO-PIP Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}